[1]
A. Noor, “CHARACTERIZATION OF BETA THALASSAEMIA MUTATIONS IN PATIENTS HAVING BORDERLINE HAEMOGLOBIN A2 LEVELS”, J Ayub Med Coll Abbottabad, vol. 36, no. 4, pp. 783–787, Nov. 2024.